What is AZN's health score?

ASTRAZENECA PLC (AZN) has a TradeApes health score of 46 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is AZN's estimated fair value?

Based on our 5-year discounted cash flow model, ASTRAZENECA PLC's estimated fair value is $164.6 per share, representing a -6.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is AZN undervalued or overvalued?

Our model currently rates AZN as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for AZN... Refresh in a moment for the full analysis.

ASTRAZENECA PLC (AZN)

Healthcare Fair Value medium mixed

$176.28

Updated: 2026-06-04

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

66 Healthy

Relative Value

35 Weak

Capital Allocation

50 Mixed

Risk

70 Healthy

Est. Fair Value $164.6

DCF Upside -6.6%

Sector Rank #2112 of 6925

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.